Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $1.1K | $34.6K | $43.1K | $0 | $0 | $0 | $0 | $0 |
| Gross profit | −$1.1K | −$34.6K | −$43.1K | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $1.4M | $1.1M | $1.2M | $1.5M | $0 | $0 | $0 | $0 |
| Operating income | −$6.3M | −$4.5M | −$3.0M | −$1.7M | −$674.0K | −$1.1M | −$318.2K | −$90.8K |
| EBITDA | −$6.3M | −$4.5M | −$3.0M | −$1.7M | −$668.0K | −$812.7K | −$239.6K | −$90.8K |
| Net income | −$6.6M | −$4.7M | −$2.9M | −$1.1M | −$1.4M | −$1.8M | −$262.5K | −$102.8K |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.07 | -0.05 | -0.03 | -0.01 | -0.00 | -0.02 | -0.03 | -0.01 |
Annual figures · source: Financial Modeling Prep
BIOCURE TECHNOLOGY INC
No one on the platform currently holds BICTF.
No tracked institution reports a position in BICTF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-10-28 | 1-for-9reverse |
No one on the platform has traded BICTF yet.
| $4M |
| — |
| EVFMEvofem Biosciences, Inc. | $0.01 | +0.00% | $1M | — |
| ISCOInternational Stem Cell Corporation | $0.18 | +0.00% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.